Genetic variants in the region of IL-23 and IL-23R have been associated with altered susceptibility to the development of IBD, and high serum IL-23 levels have been identified in patients, particularly in subjects with co-existent arthritis [14,15]. The gene discussed is IL23A; the disease is inflammatory bowel disease.